Pay in 4 interest-free payments of $7.45 Learn more
Ships within 48 hours · Estimated delivery Aug 29 - Sep 3
Some cases require medication along with lifestyle changes
By combining GLP-1, GIP and glucagon receptor activity into a single weekly injection, it has the potential to deliver greater weight loss than current therapies while also improving blood sugar control, metabolic health and markers of cardiovascular and liver disease
Additionally, in the adipose tissues of animals treated with AOD 9604, increased lipolytic activity was noted
However, long-term use may increase the risk of squamous cell skin cancer and melanoma (Archier 2012)
US$ 28.72
US$ 21.77
US$ 25.86
